REDUCTION IN PLASMA LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND URINARY MEVALONIC ACID BY LOVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引：45
|
作者：
PAPPU, AS [1 ]
ILLINGWORTH, DR [1 ]
BACON, S [1 ]
机构：
[1] OREGON HLTH SCI UNIV, DEPT MED, DIV ENDOCRINOL METAB & CLIN NUTR, L465, PORTLAND, OR 97201 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 1989年 / 38卷 / 06期
关键词：
D O I：
10.1016/0026-0495(89)90214-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 549
页数：8
相关论文
共 50 条
  • [1] CONTRASTING EFFECTS OF LOVASTATIN AND CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND 24-HOUR URINARY MEVALONATE EXCRETION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    PAPPU, AS
    ILLINGWORTH, DR
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1989, 114 (05): : 554 - 562
  • [2] Low-Density Lipoprotein Cholesterol Trajectories and Prevalence of High Low-Density Lipoprotein Cholesterol Consistent With Heterozygous Familial Hypercholesterolemia in US Children
    Zhang, Yiyi
    Woo, Jessica G.
    Urbina, Elaine M.
    Jacobs, David R., Jr.
    Moran, Andrew E.
    de Ferranti, Sarah D.
    JAMA PEDIATRICS, 2021, 175 (10) : 1071 - 1074
  • [3] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, Hayato
    Nomura, Akihiro
    Nohara, Atsushi
    Usui, Soichiro
    Sakata, Kenji
    Hayashi, Kenshi
    Fujino, Noboru
    Takamura, Masayuki
    Kawashiri, Masa-aki
    ATHEROSCLEROSIS, 2023, 371 : 61 - 66
  • [4] Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
    Tada, H.
    Nomura, A.
    Usui, S.
    Sakata, K.
    Takamura, M.
    Kawashiri, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [5] PLASMA-EXCHANGE AND LOW-DENSITY LIPOPROTEIN FILTRATION THERAPY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    TIJHUIS, GJ
    VANDOORMAAL, JJ
    RIJSKAMP, L
    SIBINGA, CTS
    DOORENBOS, H
    PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1988, 9 (01): : 29 - 34
  • [6] THE FATTY-ACID COMPOSITION OF SERUM LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND LYMPHOCYTE CHOLESTEROL ESTERS IN CHILDREN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    ANDERSEN, GE
    JOHANSEN, KB
    ACTA PAEDIATRICA SCANDINAVICA, 1980, 69 (04): : 453 - 455
  • [7] Factors Associated With Low-Density Lipoprotein Cholesterol Reduction in Patients With Familial Hypercholesterolemia: Results From Isfahan Familial Hypercholesterolemia Registry
    Vaseghi, Golnaz
    Jamalin, Marjan
    Arabi, Sina
    Kheiri, Soleiman
    Hajian, Shabnam
    Sarrafzadegan, Nizal
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (02) : E227 - E228
  • [8] Effects of colestimide in addition to atorvastatin on low-density lipoprotein (LDL) cholesterol in patients with heterozygous familial hypercholesterolemia (FH)
    Kawashiri, M
    Higashikata, T
    Tsuchida, M
    Takata, M
    Katsuda, S
    Miwa, K
    Inazu, A
    Mabuchi, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 172 - 172
  • [9] MODELLING THE US POPULATION HEALTH BENEFITS OF FURTHER LOW-DENSITY LIPOPROTEIN CHOLESTEROL REDUCTION WITH ALIROCUMAB AMONG ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL
    Sanchez, Robert
    Nasir, Khurram
    Klimchak, Alexa
    Kuznik, Andreas
    Joulain, Florence
    Briggs, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 66 - 66
  • [10] Clinical Impact of Lipoprotein (a) and Cumulative Low-Density Lipoprotein Cholesterol Exposure on Coronary Artery Disease in Patients with Heterozygous Familial Hypercholesterolemia
    Shishikura, Daisuke
    Harada-Shiba, Mariko
    Michikura, Masahito
    Fujioka, Shimpei
    Fujisaka, Tomohiro
    Morita, Hideaki
    Kanzaki, Yumiko
    Hoshiga, Masaaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025, 32 (01) : 100 - 110
12345